A double‐blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I‐745 in formula‐fed preterm infants

Xu, Liangliang; Wang, Yun; Wang, Yan; Fu, Jianhua; Sun, Mingzhe; Mao, Zhi-Qin; Vandenplas, Yvan

doi:10.1016/j.jpedp.2016.03.004

Cited by 4 publications

(8 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thirteen studies used a single strain of probiotics (Cui et al, 2019; Demirel et al, 2013; Dongol Singh et al, 2017; Hernández‐Enríquez et al, 2016; Hussain et al, 2016; Kaban et al, 2019; Oncel et al, 2014; Rojas et al, 2012; Roy et al, 2014; Serce et al, 2013; Shadkam et al, 2015; Tewari et al, 2015; Xu et al, 2016), and 13 studies used a preparation that contained multiple strains of probiotics (Amini et al, 2017; Braga et al, 2011; Chowdhury et al, 2016; Dashti et al, 2014; Dutta et al, 2015; Fernández‐Carrocera et al, 2013; Hariharan et al, 2016; Niekerk et al, 2015 (HIV exposed); Roy et al, 2014; Saengtawesin et al, 2014; Samanta et al, 2009; Shadkam et al, 2015; Sinha et al, 2015). Five studies used a preparation that had a probiotic + prebiotic (synbiotic) (Cooper et al, 2017; Dilli et al, 2015; Guney‐Varal et al, 2017; Nandhini et al, 2016; Panigrahi et al, 2017); among these five studies, three studies (Cooper et al, 2017; Dilli et al, 2015; Panigrahi et al, 2017) used a probiotic preparation that had a single strain of bacteria, and the other two studies used a preparation that had multiple strains of bacteria (Guney‐Varal et al, 2017; Nandhini et al, 2016).…”

Section: Resultsmentioning

confidence: 99%

“…Most of the studies had a minimal loss to follow‐up. One study was at high ROB where more than 20% of the participants were lost to follow‐up (Xu et al, 2016). Four studies had an unclear ROB, as there was not enough information to make an assessment in these studies (Hariharan et al, 2016; Hernández‐Enríquez et al, 2016; Huaxian, 2013; Rehman et al, 2018).…”

Section: Resultsmentioning

confidence: 99%

“…The intervention. Thirteen studies used a single strain of probiotics (Cui et al, 2019;Demirel et al, 2013;Dongol Singh et al, 2017;Hernández-Enríquez et al, 2016;Hussain et al, 2016;Kaban et al, 2019;Oncel et al, 2014;Roy et al, 2014;Shadkam et al, 2015;Tewari et al, 2015;Xu et al, 2016), and 13 studies used a preparation that contained multiple strains of probiotics (Amini et al, 2017;Braga et al, 2011;Chowdhury et al, 2016;Dashti et al, 2014;Dutta et al, 2015;Fernández-Carrocera et al, 2013;…”

Section: Probiotic Supplementation During Neonatal Periodmentioning

confidence: 99%

See 2 more Smart Citations

Effects of neonatal nutrition interventions on neonatal mortality and child health and development outcomes: A systematic review

Imdad

Rehman

Davis

et al. 2021

Campbell Systematic Reviews

View full text Add to dashboard Cite

Background The last two decades have seen a significant decrease in mortality for children <5 years of age in low and middle‐income countries (LMICs); however, neonatal (age, 0–28 days) mortality has not decreased at the same rate. We assessed three neonatal nutritional interventions that have the potential of reducing morbidity and mortality during infancy in LMICs. Objectives To determine the efficacy and effectiveness of synthetic vitamin A, dextrose oral gel, and probiotic supplementation during the neonatal period. Search Methods We conducted electronic searches for relevant studies on the following databases: PubMed, CINAHL, LILACS, SCOPUS, and CENTRAL, Cochrane Central Register for Controlled Trials, up to November 27, 2019. Selection Criteria We aimed to include randomized and quasi‐experimental studies. The target population was neonates in LMICs. The interventions included synthetic vitamin A supplementation, oral dextrose gel supplementation, and probiotic supplementation during the neonatal period. We included studies from the community and hospital settings irrespective of the gestational age or birth weight of the neonate. Data Collection and Analysis Two authors screened the titles and extracted the data from selected studies. The risk of bias (ROB) in the included studies was assessed according to the Cochrane Handbook of Systematic Reviews. The primary outcome was all‐cause mortality. The secondary outcomes were neonatal sepsis, necrotizing enterocolitis (NEC), prevention and treatment of neonatal hypoglycaemia, adverse events, and neurodevelopmental outcomes. Data were meta‐analyzed by random effect models to obtain relative risk (RR) and 95% confidence interval (CI) for dichotomous outcomes and mean difference with 95% CI for continuous outcomes. The overall rating of evidence was determined by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. Main Results Sixteen randomized studies (total participants 169,366) assessed the effect of vitamin A supplementation during the neonatal period. All studies were conducted in low‐ and middle‐income (LMIC) countries. Thirteen studies were conducted in the community setting and three studies were conducted in the hospital setting, specifically in neonatal intensive care units. Studies were conducted in 10 different countries including India (four studies), Guinea‐Bissau (three studies), Bangladesh (two studies), and one study each in China, Ghana, Indonesia, Nepal, Pakistan, Tanzania, and Zimbabwe. The overall ROB was low in most of the included studies for neonatal vitamin A supplementation. The pooled results from the community based randomized studies showed that there was no significant difference in all‐cause mortality in the vitamin A (intervention) group compared to controls at 1 month (RR, 0.99; 95% CI, 0.90–1.08; six studies with 126,548 participants, statistical heterogeneity I2 0%, funnel plot symmetrical, grade rating high), 6 months (RR, 0.98; 95% CI, 0.89–1.07; 12 studies with 154,940 participan...

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Probiotic Supplementation During Neonatal Periodmentioning

confidence: 99%

See 1 more Smart Citation

Effects of neonatal nutrition interventions on neonatal mortality and child health and development outcomes: A systematic review

Imdad

Rehman

Davis

et al. 2021

Campbell Systematic Reviews

View full text Add to dashboard Cite

show abstract

“…Oesophageal Atresia-Tracheoesophageal Fistula (OA-TOF) is one of the commonest malformations of the GI tract, occurring in around 1 in 3000 births worldwide (84,85).…”

Section: Oesophageal Atresiamentioning

confidence: 99%

“…Medium-longer term consequences of OA-TOF corrections that are likely to impact on the patient health and quality of life in childhood and adolescence include gastroesophageal reflux disease (GORD), peptic esophagitis (86), chronic aspiration (87,88), gastric metaplasia and Barrett oesophagus, anastomotic strictures, feeding disorders, dysphagia, and oesophageal dysmotility (89). In the adult age, the main concerns include oesophageal adenocarcinoma and epidermoid carcinoma (84).…”

Section: Oesophageal Atresiamentioning

confidence: 99%

Making Research Flourish Through ESPGHAN

Gasparetto

Strisciuglio

Assa

et al. 2021

J. pediatr. gastroenterol. nutr.

View full text Add to dashboard Cite

Recent research breakthroughs have emerged from applied basic research throughout all scientific areas, including adult and paediatric gastroenterology, hepatology and nutrition (PGHAN). The research landscape within the European Society of Paediatric Gastroenterology and Nutrition (ESPGHAN) is also inevitably changing from clinical research to studies involving applied laboratory research. This position paper aims to depict the current status quo of basic science and translational research within ESPGHAN, and to delineate how the society could invest in research in the present and future time. The paper also explores which research areas in the field of PGHAN represent the current and future priorities, and what type of support is needed across the ESPGHAN working groups (WGs) and special interest groups (SIGs) to fulfil their research goals.

show abstract

Microbial Impact on Host Metabolism: Opportunities for Novel Treatments of Nutritional Disorders?

Plovier

Cani

2017

Microbiol Spectr

View full text Add to dashboard Cite

Malnutrition is the cause of major public health concerns worldwide. On the one hand, obesity and associated pathologies (also known as the metabolic syndrome) affect more than 10% of the world population. Such pathologies might arise from an elevated inflammatory tone. We have discovered that the inflammatory properties of high-fat diets were linked to the translocation of lipopolysaccharide (LPS). We proposed a mechanism associating the gut microbiota with the onset of insulin resistance and low-grade inflammation, a phenomenon that we called "metabolic endotoxemia." We and others have shown that bacteria as well as host-derived immune-related elements control microbial communities and eventually contribute to the phenotype observed during diet-induced obesity, diabetes, and metabolic inflammation. On the other hand, undernutrition is one of the leading causes of death in children. A diet poor in energy and/or nutrients causes incomplete development of the gut microbiota and may profoundly affect energy absorption, initiating stunted growth, edema, and diarrhea. In this review, we discuss how changes in microbiota composition are associated with obesity and undernutrition. We also highlight that opposite consequences exist in terms of energy absorption from the diet (obesity versus undernutrition), but interestingly the two situations share similar defects in term of diversity, functionality, and inflammatory potential.

show abstract

A double‐blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I‐745 in formula‐fed preterm infants

Cited by 4 publications

References 22 publications

Effects of neonatal nutrition interventions on neonatal mortality and child health and development outcomes: A systematic review

Effects of neonatal nutrition interventions on neonatal mortality and child health and development outcomes: A systematic review

Making Research Flourish Through ESPGHAN

Microbial Impact on Host Metabolism: Opportunities for Novel Treatments of Nutritional Disorders?

Contact Info

Product

Resources

About